172 related articles for article (PubMed ID: 34165262)
1. Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1.
Biewenga M; Verhelst XPDMJ; Baven-Pronk MAMC; Putter H; van den Berg AP; van Nieuwkerk KCMJ; van Buuren HR; Bouma G; de Boer YS; Simoen C; Colle I; Schouten J; Sermon F; van Steenkiste C; van Vlierberghe H; van der Meer AJ; Nevens F; van Hoek B;
United European Gastroenterol J; 2021 Jul; 9(6):662-671. PubMed ID: 34165262
[TBL] [Abstract][Full Text] [Related]
2. Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.
van den Brand FF; van der Veen KS; de Boer YS; van Gerven NM; Lissenberg-Witte BI; Beuers U; van Erpecum KJ; van Buuren HR; den Ouden JW; Brouwer JT; Vrolijk JM; Verdonk RC; van Hoek B; Koek GH; Drenth JPH; Guichelaar MMJ; Mulder CJJ; Bloemena E; van Nieuwkerk CMJ; Bouma G;
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):940-947.e2. PubMed ID: 30291909
[TBL] [Abstract][Full Text] [Related]
3. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
Ngu JH; Gearry RB; Frampton CM; Stedman CA
Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis.
Danielsson Borssén Å; Marschall HU; Bergquist A; Rorsman F; Weiland O; Kechagias S; Nyhlin N; Verbaan H; Nilsson E; Werner M
Scand J Gastroenterol; 2017 Sep; 52(9):1022-1028. PubMed ID: 28562110
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
[TBL] [Abstract][Full Text] [Related]
6. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score.
De Martin E; Coilly A; Chazouillères O; Roux O; Peron JM; Houssel-Debry P; Artru F; Silvain C; Ollivier-Hourmand I; Duvoux C; Heurgue A; Barge S; Ganne-Carrié N; Pageaux GP; Besch C; Bourlière M; Fontaine H; de Ledinghen V; Dumortier J; Conti F; Radenne S; Debette-Gratien M; Goria O; Durand F; Potier P; Di Martino V; Reboux N; Ichai P; Sebagh M; Mathurin P; Agostini H; Samuel D; Duclos-Vallée JC;
J Hepatol; 2021 Jun; 74(6):1325-1334. PubMed ID: 33503489
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center.
Hoeroldt B; McFarlane E; Dube A; Basumani P; Karajeh M; Campbell MJ; Gleeson D
Gastroenterology; 2011 Jun; 140(7):1980-9. PubMed ID: 21396370
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response.
Werner M; Wallerstedt S; Lindgren S; Almer S; Björnsson E; Bergquist A; Prytz H; Sandberg-Gertzén H; Hultcrantz R; Sangfelt P; Weiland O; Ohlsson B; Danielsson A
Scand J Gastroenterol; 2010 Apr; 45(4):457-67. PubMed ID: 20082594
[TBL] [Abstract][Full Text] [Related]
9. Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis.
Gerussi A; Halliday N; Saffioti F; Bernasconi DP; Roccarina D; Marshall A; Thorburn D
Dig Liver Dis; 2020 Jul; 52(7):761-767. PubMed ID: 32473882
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents.
Porta G; de Carvalho E; Santos JL; Gama J; Bezerra JA;
J Pediatr; 2021 Feb; 229():95-101.e3. PubMed ID: 33500120
[TBL] [Abstract][Full Text] [Related]
11. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
[TBL] [Abstract][Full Text] [Related]
12. Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis.
Biewenga M; Verhelst X; Baven-Pronk M; Putter H; van den Berg A; Colle I; Schouten J; Sermon F; Van Steenkiste C; van Vlierberghe H; van der Meer A; van Hoek B;
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1776-1783.e4. PubMed ID: 34022454
[TBL] [Abstract][Full Text] [Related]
13. Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters.
van der Meer AJ; Hansen BE; Fattovich G; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Manns MP; Ieluzzi D; Zeuzem S; Hofmann WP; de Knegt RJ; Veldt BJ; Janssen HL
Gut; 2015 Feb; 64(2):322-31. PubMed ID: 24815676
[TBL] [Abstract][Full Text] [Related]
14. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
[TBL] [Abstract][Full Text] [Related]
15. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
[TBL] [Abstract][Full Text] [Related]
16. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis.
Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA
Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.
Montano-Loza AJ; Vargas-Vorackova F; Ma M; Bain VG; Burak K; Kumar T; Mason AL
Liver Int; 2012 Oct; 32(9):1426-33. PubMed ID: 22712495
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study).
Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Ohta H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Komori A; Ito M; Yatsuhashi H; Nakamura M; Ishibashi H;
Liver Int; 2012 May; 32(5):837-44. PubMed ID: 22221966
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study.
Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Morimoto H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Yano K; Komori A; Yatsuhashi H; Nakamura M; Ishibashi H
J Gastroenterol; 2011 Jan; 46 Suppl 1():56-62. PubMed ID: 21042923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
